| Financial Year |
March 31 2023 |
| Monetary Funds |
269,582,899.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,072,943.81 |
| Accounts Receivable |
1,154,848,204.84 |
| Advances to Suppliers |
24,019,288.96 |
| Other Receivables |
47,250,161.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
293,595,075.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,646,803.48 |
| Total Current Assets |
1,928,489,221.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,917,364.62 |
| Investment Properties |
-- |
| Fixed Assetes |
419,715,899.63 |
| Under-construction Projects |
197,468,530.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
133,720,126.81 |
| R&D expenses |
-- |
| Goodwill |
26,618,494.73 |
| Long-Term Deferred and Prepaid Expenses |
7,365,858.01 |
| Deferred Income Tax Assets |
25,849,344.93 |
| Other Non-Current Assets |
52,922,298.22 |
| Sub-Total of Non-Current Assets |
917,092,686.39 |
| Total Assets |
2,845,581,907.87 |
| Short-Term Loans |
642,302,487.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
43,960,000.00 |
| Accounts Payable |
384,324,415.46 |
| Accounts Received In Advance |
580,182.34 |
| Employee Compensation Payable |
23,945,222.07 |
| Taxes Payable |
15,131,590.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,743,419.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,259,184.26 |
| Other Current Liabilities |
5,245,588.89 |
| Sub-Total of Current Liabilities |
1,179,997,876.71 |
| Long-term Loans |
107,941,193.80 |
| Bonds Payable |
72,161,718.63 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
660,234.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
202,781,979.05 |
| Total Liabilities |
1,382,779,855.76 |
| Paid-In Capital(Or Share Stock) |
364,978,588.00 |
| Capital Surplus |
361,698,202.77 |
| Surplus Reserve |
55,915,199.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
625,867,190.52 |
| Minority Stockholder's Interest |
41,628,571.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,421,173,480.19 |
| Owner's Equity（Stockholder's Equity） |
1,462,802,052.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,845,581,907.87 |
